Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)
$6.02
+0.0500 ( +0.84% ) 75.5K
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Market Data
Open
$6.02
Previous close
$5.97
Volume
75.5K
Market cap
$77.88M
Day range
$5.94 - $6.12
52 week range
$3.21 - $23.52
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 29, 2024 |
4 | Insider transactions | 1 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 13, 2024 |
4 | Insider transactions | 1 | Feb 06, 2024 |
8-k | 8K-related | 14 | Jan 18, 2024 |
8-k | 8K-related | 13 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 09, 2024 |
4 | Insider transactions | 1 | Jan 09, 2024 |
8-k/a | 8K-related | 14 | Dec 22, 2023 |